Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001444 |
---|---|
Receipt number | R000001651 |
Scientific Title | Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer. |
Date of disclosure of the study information | 2008/10/22 |
Last modified on | 2017/04/30 18:25:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/10/21 10:41:32 | ||
2 | Update | 2009/09/15 19:54:33 | Recruitment status |
|
3 | Update | 2009/09/17 09:24:14 | UMIN ID1 |
|
4 | Update | 2009/10/28 12:42:24 | UMIN ID2 |
|
5 | Update | 2009/11/20 11:49:22 | Organization Organization Organization1 Institutions |
|
6 | Update | 2010/11/19 08:29:36 | Name of person sending information Organization Division name Division name Address |
|
7 | Update | 2010/11/19 08:31:58 | Publication of results |
|
8 | Update | 2011/05/24 09:05:06 | Email |
|
9 | Update | 2013/11/20 09:29:07 | TEL Last name of contact person Last name of contact person Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
10 | Update | 2013/11/20 09:32:42 | Results |
|
11 | Update | 2014/05/21 09:58:31 | Email1 |
|
12 | Update | 2014/05/21 10:25:41 | Last name of contact person Last name of contact person |
|
13 | Update | 2014/05/21 10:38:14 | Last follow-up date |
|
14 | Update | 2015/05/22 08:00:14 | Email Email1 |
|
15 | Update | 2017/01/13 13:24:25 | Name of primary person or sponsor Organization |
|
16 | Update | 2017/01/13 13:24:59 | Anticipated trial start date |
|
17 | Update | 2017/01/13 13:38:51 | Public title |
|
18 | Update | 2017/04/30 18:25:58 | Recruitment status |